Bio Bench has started a partnership with Helixar Biosciences to support its Europe and North America market development.
Helixar Biosciences is focusing on the communication and logistic for Bio Bench products and services. In a first stage, it focused on the SARS-Cov-2 related products but since June 1 it has extended its services to all Bio Bench portfolio.
“To better support the European and Northern American research institutes and biotech industry, we have decided to extend our collaboration with Helixar Biosciences,” added Jiuhua Liu, the CEO of Bio Bench.
About Bio Bench
Bio Bench is a biotechnology CRO company specialized in the development of functional antibodies and biologically active proteins for drug discovery, IVD kit and biological research.
About Helixar Biosciences
Helixar Biosciences is a consulting agency focused on the biotechnology and pharmaceutical market.
For more information, please contact:
Renfeng Liu
General Manager
info@bio-bench.com
+32 497 29 31 19
Let’s block ads! (Why?)
“Engineered for Sustainability: Hong Kong’s Contribution to United Nations Sustainable Development Goals” Showcasing over 40…
Delta Dunia Group, via its indirect subsidiary BUMA International [1], will expand its presence in…
SINGAPORE - Media OutReach Newswire - 25 November 2024 - FBS, a leading global broker,…
Exploring the Unique Characteristics of Tsuen Wan and Sha Tau Kok and Presenting Hong Kong’s…
A Collaborative Platform Showcasing Scalable and Affordable Solutions for Climate Action, With a Focus on…
Reducing waste by collaborating with the World Green Organisation and a local farm to upcycle…